Previous studies have shown that obesity increases the number of chemokines and chemokine receptors in fat tissue. Research has identified various immune cells as metabolic controllers with pathogenic or regulatory potential. Three T lymphocyte subsets might play distinct roles in adipose tissue immune homeostasis. In particular, the infiltration of CD8+ T cells to the adipose tissue has been shown to precede macrophage influx into the obese fat tissues and CD8+ T cells are involved in macrophage recruitment in obesity. With studies showing that the immune system plays a role in obesity, the lab state that it should be noted that the majority of these studies were performed on mice deliberately fed a high-fat diet. The current study was performed on mice fed a regular diet; with results showing that immunological mechanisms can play a role in obesity and metabolic syndrome without any connection to dietary fat.
The current study focused on dendritic cells, with the emphasis on a rare subtype of dendritic cells possessing a killing protein called perforin that enables them to eliminate other cells on demand. To reveal the function of these cells in the body, the lab used mice that lacked perforin-rich dendritic cells. Results show that these mice became overweight and then developed symptoms of metabolic syndrome. Data findings show that fat tissue had abnormally high levels of inflammation-causing immune T cells.
Results show that when these cells were removed from the fat tissue of the mice lacking perforin-rich dendritic cells, the mice did not grow obese. The researchers conclude that these findings suggest that perforin-rich dendritic cells regulate the levels of certain T cells, and by keeping these T cells in check, they apparently prevent metabolic syndrome.
The team surmise that in addition to providing new insights into metabolic syndrome, the study may also shed new light on autoimmunity as the mice lacking perforin-rich dendritic cells were more prone than usual to develop an autoimmune disease equivalent to multiple sclerosis in humans. For the future, the researchers state that it now remains to be investigated whether patients with autoimmune disease lack these regulatory cells.
Source: Weizmann Institute
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.